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O presente trabalho reporta a caracterização espectroscópica por absorção UV-visível, dicroísmo 
circular magnético (MCD) e ressonância paramagnética eletrônica (EPR) da proteína recombinante 
do tipo P450-canfora (P450CAM) codificada pela orf10 de Streptomyces clavuligerus (P450CLA) 
expressa por Escherichia coli Rosetta na forma nativa e associada a ligantes externos contendo os 
grupos β-lactamato, oxazol e derivado de alquilamina (álcool) do ácido clavulâmico. Considerando 
a diversidade de aplicações da enzima P450, sua reatividade com terc-butil-hidroperóxido 
(terc-BuOOH) foi caracterizada. O grupo heme da P450CLA apresenta-se covalentemente ligado e 
exibe características espectrais de UV-visível, CD e MCD de P450CAM, incluindo a banda Soret 
em 450 nm proveniente do complexo ferroso-CO. P450CLA foi convertido em espécies de valência 
alta pelo terc-BuOOH e promoveu cisão homolítica da ligação O−O. O perfil radicalar da reação 
foi terc-butiloxil como radical primário e metil e butilperoxil como radicais secundários. Os 
radicais metil e butilperoxil resultaram respectivamente da cisão-β do radical alcoxil e da reação 
do radical metil com oxigênio molecular.
The present study reports the spectroscopic characterization by UV-visible absorption 
spectroscopy, magnetic circular dichroism (MCD) and electron paramagnetic resonance (EPR) of the 
recombinant orf10-encoded P450-camphor like protein (P450CLA) of Streptomyces clavuligerus 
expressed in Escherichia coli Rosetta in the native form and associated to external ligands containing 
the β-lactam, oxazole and alkylamine-derived (alcohol) moieties of the clavulamic acid. Considering 
the diversity of potential applications for the enzyme, the reactivity with tert-butylhydroperoxide 
(tert-BuOOH) was also characterized. P450CLA presents a covalently bound heme group and 
exhibited the UV-visible, CD and MCD spectral features of P450CAM including the fingerprint 
Soret band at 450 nm generated by the ferrous CO-complex. P450CLA was converted to high 
valence species by tert-BuOOH and promoted homolytic scission of the O−O bond. The radical 
profile of the reaction was tert-butyloxyl as primary and methyl and butylperoxyl as secondary 
radicals. The secondary methyl and butylperoxyl radicals resulted respectively from the β-scission 
of the alkoxyl radical and from the reaction of methyl radical with molecular oxygen.
Keywords: cytochrome P450, orf10, peroxidase activity, magnetic circular dichroism, electron 
paramagnetic resonance, spin trapping
Introduction
Based on the specific sequence homology, the orf10 
gene of Streptomyces clavuligerus has been assigned 
to potentially encoding for a cytochrome P450-like 
enzyme. S. clavuligerus orf10 knockout mutant lacks 
the production of clavulanic acid, which has led to the 
proposal that orf10 plays a yet uncharacterized role in 
the clavulanic acid biosynthetic pathway.1-5 Clavulanic 
acid is a secondary metabolite that has a fused bicyclic 
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β-lactam/oxazolidine ring system similar to penicillin.6 
Despite sharing the β-lactam ring structure, clavulanic 
acid has negligible antibiotic activity. However, this 
structural similarity to penicillin allows the molecule to 
act as a competitive inhibitor of secreted β-lactamases and 
hence restores the activity of common β-lactam antibiotics 
against β-lactam-resistent bacteria. In this regard, one 
of the major obstacles to the demonstration of orf10’s 
involvement in the clavulanic acid pathway is that 
the substrates for orf10-encoded protein catalysis are 
unavailable. Another difficulty resides in the predicted, 
widely accepted involvement of additional proteins in the 
catalysis. The S. clavuligerus class I P450 orf10-encoded 
protein (P450CLA)4 is denoted as CYP105M1.7-9 The 
P450 superfamily is poorly conserved and only three 
residues are almost invariantly conserved, including a 
totally conserved cysteine that serves as the fifth ligand 
for the heme iron, and the EXXR motif that is highly 
conserved.10
Considering the interest in the potential therapeutic use 
of clavulanic acid and a diversity of potential applications 
for P450 proteins, a better characterization of the 
orf10-encoded protein is relevant. In the present study, for 
the first time, electronic absorption spectroscopy, circular 
dichroism (CD), magnetic circular dichroism (MCD) and 
electron paramagnetic resonance (EPR) were used to 
corroborate that orf10 encodes a functional cytochrome 
P450-like enzyme putatively required for the synthesis of 
clavulanic acid.
Experimental
General procedures
Streptomyces clavuligerus ATCC 27064 was purchased 
from the American Type Culture Collection (Manassas, 
VA) and stored at –80 °C in 40% v/v glycerol. Custom 
oligonucleotides were provided by IDT (Integrated 
DNA Technologies, Coralville, IA). Restriction 
enzymes were obtained from Promega (Madison, WI). 
PCR reagents and cloning vectors were supplied by 
Fermentas (Glen Burnie, MD). Dimethylsulphoxide 
(DMSO), 5-aminolevulinic acid (ALA), sodium 
dithionite, tert-butyl-hydroperoxide (tert-BuOOH), 
clavulanic acid (potassium clavulanate), ampicillin, 
camphor, glycine, proline, histidine, glycyl-histidine, 
3-amino-1,2,4-triazole, imidazole, histamine and 
5,5-dimethyl-1-pyrroline N-oxide (DMPO) were 
purchased from Sigma (St. Louis, MO). Other reagents 
were of analytical grade or higher. Standard microbial and 
recombinant DNA techniques used throughout this 
work were previously described,11 or are detailed 
in the text.
Cloning, construction of expression systems, recombinant 
expression and protein purification
See online Supplementary Information (SI) section.
Absorption spectroscopy
Absorption UV-visible spectra were obtained at 
room temperature in a 500 μL quartz cuvette (1 cm 
light path length) loaded into a Hitachi U-2800 UV-vis 
spectrophotometer (Hitachi, Hitachi City, Ibaraki 
Prefecture). Spectra were measured from 700 to 350 nm and 
recorded in 1 nm intervals using a 500 μL sample containing 
17 × 10-6 mol L-1 of protein in 100 mmol L-1 NaCl, 
50 mmol L-1 Tris-HCl, pH 8.0. For the ferric water-bound 
form, the sample was scanned under the described 
conditions. The ferrous CO-complex was measured after 
anaerobic (N2 environment) 5 min of mild bubbling with 
CO, followed by the addition of a molar excess of sodium 
dithionite. The substrate sub-structural analogue binding 
complexes were measured in the ferric state and registered 
after arbitrary successive addition of each ligand solid 
salt to 500 μL protein samples at 8 × 10-6 mol L-1 until 
no appreciable spectral changes were seen. Later, the 
complexes were reduced to the ferrous forms by anaerobic 
addition of sodium dithionite.
The expected covalent attachment of heme iron to the 
peptide chain was tested by the incubation of the protein 
at strongly acid pH, a condition in which no covalent heme 
iron detaches from the unfolded protein and precipitates 
at the bottom of the test tube. The electronic absorption 
spectrum of the hemeprotein was briefly measured at 
pH 8.0 to ascertain the presence of P450-CO species, and 
then another electronic absorption spectrum was measured 
for the same protein at pH 2.0. At pH 2.0, no significant 
spectral change indicative of heme iron loss was detected 
in the sample before and after centrifugation (10 min at 
400 × g) consistent with covalently bound heme iron.
Circular dichroism spectroscopy
CD measurements were performed at  room 
temperature using a J-720 (JASCO Inc., Easton, MD) 
spectropolarimeter and a 0.1 cm quartz cuvette. Two 
wavelength ranges were used depending on the targeted 
chromophore (the protein structure or the heme iron). For 
secondary structure determination, a 4 × 10-6 mol L-1 protein 
solution in 50 × 10-3 mol L-1 Tris-HCl pH 8.0 containing 
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50 × 10-3 mol L-1 NaCl and 10% v/v glycerol was measured 
in the far-UV wavelength range (250-195 nm) and recorded 
as an average of 8 scans at 100 nm min-1 using a 0.1 nm data 
pitch dump. Secondary and tertiary structural predictions 
were done using the CDPro software package.12-14 For heme 
iron measurements, a 0.13 × 10-3 mol L-1 protein solution 
in 16 × 10-3 mol L-1 sodium phosphate pH 7.4 containing 
50 × 10-3 mol L-1 NaCl was measured in the near-UV-visible 
range (700-350 nm). Spectra were recorded as an average 
of 16 scans at 400 nm min-1, collecting data points every 
0.2 nm, both with (MCD) and without a magnetic field of 
860 mT.
Electron paramagnetic resonance (EPR) of heme iron in 
the absence and presence of tert-BuOOH
Continuous wave EPR spectra were recorded at 
−248 °C (25 K) in a Bruker Elexsys line E-580 X-band 
spectrometer (Bruker, Billerica, MA) equipped with 
a standard rectangular cavity and an Oxford cryostat 
system containing liquid helium (Oxford Instruments, 
Abingdon, Oxfordshire). The microwave frequency was 
set to 9.47607 GHz, using 1 mW power and sweeping the 
magnetic field from 25 to 425 mT. A 50 μL protein sample 
at a concentration of 250 × 10-6 mol L-1 in 50 × 10-3 mol L-1 
Tris-HCl pH 8.0 containing 100 × 10-3 mol L-1 NaCl and 
10% v/v glycerol was loaded into a quartz cell and frozen in 
liquid nitrogen prior to being measured. This measurement 
was set as the initial state. For scans at subsequent times, 
30 μL of aqueous 1.25 mol L-1 tert-BuOOH, exceeding 
3000 fold the tert-BuOOH/protein molar ratio, was added 
to the sample. 
Spin trapping EPR measurements
EPR spectra were recorded at room temperature using 
a Varian E-109 spectrometer (Varian Inc., Palo Alto, CA) 
operating at 9.5091 GHz in a rectangular cavity. DMPO 
was used as an EPR spin trap for the radical adducts 
formed on reacting tert-BuOOH with P450CLA. 50 μL 
samples with 8 × 10-6 mol L-1 protein in 50 × 10-3 mol L-1 
Tris-HCl, pH 8.0 containing 100 × 10-3 mol L-1 NaCl and 
10% v/v glycerol had separate additions of DMPO up to 
160 × 10-3 mol L-1 and 650 × 10-3 mol L-1. Each sample 
was loaded into a flat quartz cell and the reactions 
were initiated by the addition of tert-BuOOH (up to 
375 × 10-3 mol L-1). After approximately 2 min of 
incubation following the addition of tert-BuOOH, EPR 
measurements were performed in the range 334-344 mT. 
Simulations were performed using the SimFonia computer 
program from Bruker.
Results and Discussion
The sequence of the S. clavuligerus orf10-encoded protein 
is consistent with a P450 enzyme and yielded a structured 
protein with covalently bound heme
As described in the Supplementary Information (SI) 
section, two oligonucleotides were synthesized as PCR 
primers to produce the engineered P450CLA-encoding 
DNA for expression experiments. According to the targeted 
DNA sequence, the PCR experiment should result in an 
amplification product with the mass (corresponding to about 
1200 bp) that was effectively detected by 0.8% agarose 
TAE electrophoresis (data not shown). The full-length 
sequence of the cloned DNA fragment was identical to 
that expected (GenBank accession codes AY034175 and 
AAF85938). The protein sequence predicted from the 
DNA sequence was computationally analyzed.15,16 In the 
analyzed sequence, a cysteine-containing potential heme 
binding motif (FGHGMHQCLG) was found. Besides the 
one cysteine residue that is a totally conserved distal heme 
iron ligand, the well-conserved EXXR motif characteristic 
of P450s was also identifiable. The predicted primary 
sequence of the protein encoded by orf10 was aligned 
with CYP105A1,17 the closest BLAST18 match that has a 
solved structure (41% identity), and with CYP101A1 (22% 
identity), which is the most well-known bacterial P450 
(P450CAM) (Figure S1).
The cloned PCR product was subcloned into the 
pET28a vector and transformed into E. coli Rosetta 
(DE3) for heterologous production of the orf10-encoded 
protein. As expected, recombinant CYP105M1 (herein 
named P450CLA) yielded an additional over expression 
band of approximately 45 kDa (Figure S2). P450CLA 
was isolated from the crude soluble cell lysate using the 
IMAC (immobilized metal-ion affinity chromatography) 
procedure, and purified to homogeneity using ion-exchange 
chromatography (Figure S2). Native PAGE (polyacrylamide 
gel electrophoresis, PhastSystem, GE Healthcare) 
(not shown) and size-exclusion chromatography on a 
Superdex 200 (GE Healthcare) indicated that the purified 
protein was obtained as a monomer of the expected size 
(not shown). Purified P450CLA was injected into mice for 
the production of anti-CYP105M1 sera that was effective to 
recognize a protein with equivalent mass in immunoblotting 
assays performed with S. clavuligerus ATCC 27064 cell 
extract (not shown).
The presence of a covalently bound heme group was 
corroborated by a denaturation (see Experimental section) 
assay followed by centrifugation. The pellet did not contain 
protoporphyrn IX and the supernatant that remained 
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exhibited electronic absorption spectrum with the Soret and 
Q bands typical of the hemeprotein (not shown).
Far-UV CD of the protein showed two negative bands 
peaking at 220 and 208 nm (Figure S3), indicating an 
α + β structured protein. Secondary and tertiary structure 
predictions were generated using CDPro.13,14 Predictions 
made using a 56-protein reference set confirmed the 
α + β spectrum class, and yielded 27% regular α-helices, 
18% distorted helices, 5% regular β-strands, 6% distorted 
strands, 17% turns and 27% unordered structures.
The orf10-encoded protein exhibited UV-visible and MCD 
spectral features of P450-CAM including the fingerprint 
Soret band at 450 nm by the ferrous CO-complex
The orf10-encoded P450CLA protein was analyzed by 
electronic absorption spectroscopy and exhibited spectral 
features consistent with a P450 protein. The features 
exhibited by the UV-visible absorbance spectrum of the 
P450CLA resting form matched totally those previously 
described for P450CAM isolated and purified from 
Pseudomonas putida:19 a Soret band maximum at 417 nm 
with ε = 62100 mol-1 L cm-1, Qα band peaking at 570 nm, 
more intense than the Qβ band peaking at 536 nm and also 
a relatively well defined peak at 356 nm (Figure 1A).
As expected for the complexes with transition metals 
exhibiting vacant d-orbitals that participate in charge 
transfer transitions, a complex MCD spectrum was 
obtained for P450CLA. In a hemeprotein, the presence 
of a partially filled set of d-orbitals results in ligand to 
metal and metal to ligand transitions that are responsible 
for the charge transfer bands (LMCT, MLCT) observed in 
both UV-visible and MCD spectra and, in addition, for the 
π → π* bands.20,21 The room temperature MCD spectrum 
for the resting P450CLA heme closely matched that 
reported for P450CAM of P. putida.19 The MCD spectrum 
of P450CLA (Figure 1B) obtained after the subtraction of 
CD signals presents a pair of oppositely signed MCD bands 
of nearly equal amplitude that peak at 427 and 409 nm with 
the zero crossing at the absorption maximum at 418 nm. 
At longer weaker wavelengths, they are found as a positive 
band at 559 nm and a negative band at 579 nm.
The derivative shape of MCD bands is normally 
indicative of a predominant contribution of a Faraday A 
term, but, in the present condition, the slight distortion of 
the symmetrical A term in a positive direction indicates 
an intermediate case in which a B term is also present. 
Therefore, probably the spectrum results from the 
contribution of a set of degenerate metal d-orbitals split by 
the magnetic field (Zeeman effect) and associated with the 
mixing of an intermediate state (|K〉) with an excited state 
(|J〉) of the rhombically distorted porphyrin. The double 
spectral contribution becomes evident when comparing the 
CD spectra with the MCD spectra from which the CD signal 
was not subtracted. The comparison provides evidence 
that when the magnetic field is applied to the system, the 
contribution of a derivative shape becomes almost the 
absolute contribution after the CD signal was subtracted.21
In addition, the fingerprint of the P450 enzymes, i.e., 
the red shift of the Soret band to 450 nm observed for the 
ferrous CO-complex was obtained after sodium dithionite 
addition in P450CLA samples under CO atmosphere 
(Figure 2A). The red shift of the Soret band to 450 nm 
exhibited by the ferrous-CO-complex of P450CLA is the 
low energy component of a split Soret band system (the 
hyperporphyrin),22 in which the high energy component is 
near 370 nm.
Although without a consensus for the identification 
of orbitals contributing for the mixing mechanism, these 
peculiar spectral features arise from orbital mixing. Similar 
to the MCD spectrum reported for P450CAM and similar 
proteins,19,23,24 the MCD spectrum of ferrous-CO-complex 
P450CLA presented a derivative shape band with zero 
crossing around 450 nm (Figure 2B). In contrast to 
the experimental conditions used for the UV-visible 
spectroscopic measurements, in which all of the P450CAM 
was in the complexed ferrous form, a significant amount 
of the P450CAM was in the non-complexed ferrous form 
for the experimental conditions used for the MCD spectral 
measurements. The cause is the higher concentration of 
Figure 1. Spectroscopic characteristics of P450CLA. (A) Electronic 
absorption (insert: zooming of α and β band regions) and (B) CD 
(dashed line), MCD-CD (gray line) and MCD (black line) spectra of 
15 × 10-3 mol L-1 P450CLA. The spectra were obtained as described in 
the Experimental section.
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protein required for the MCD measurements in contrast 
to that required for the UV-visible measurements. Here, 
due to the limited solubility of CO in the buffer solution, 
not all of the protein is in the CO-complexed form. The 
partial conversion to CO-complex in the MCD experimental 
conditions precluded detection of a significant and 
confident MCD signal of the ferrous-CO-complex due to 
the overlap of bands.
As described above, the CD spectrum of P450CLA 
shows a negative Soret band with an absorption shape and 
does not exhibit the contribution of a derivative band 
shape that is added by the presence of a magnetic field. 
For P450CAM, a derivative shape band with zero crossing 
around 450 nm is present in the CD spectrum of the ferrous-
CO-complex in addition to the negative absorption shape 
band that remains present but blue shifted relative to that 
obtained for the resting form. The presence of a derivative 
CD band for the ferrous-CO-complex can be seen by the 
splitting of the degenerate d-orbital energy levels at zero 
field induced by CO binding of the heme iron axial ligand 
at the sixth coordination position25 (see in Figure 2B the 
significant reminiscent MCD signal of the ferrous form that 
remains present after CO purging).
According to Hanson et al.,26 a charge transfer occurs 
from the lone pair p-orbital of the cysteinate sulfur to the 
porphyrin π*-orbitals leading to the splitting of the doubly 
degenerate porphyrin π-π*-orbital energy levels. However, 
according to Jung and Ristau,27 the split Soret band results 
from the charge-transfer transitions from an axial system 
consisting of cysteinate π-orbitals, CO π-orbitals, and the 
dπ-orbitals of ferrous iron to the porphyrin π*-orbitals 
mixed with the π-π* porphyrin transitions. Whatever the 
mechanism responsible for the split Soret band in the 
absence of CO, the orbital split can be induced by the 
magnetic field (Zeeman effect) and the derivative shape 
band is observed only in the MCD spectra. According to the 
ligand field theory, the presence of CO induces degenerate 
orbital splitting and a derivative shape band is observed 
at zero field. In this regard, the comparison of ferric 
resting and ferrous CO-complex P450CLA spectra should 
also consider the redox state of heme iron. It is reported that 
the heme ligand acts as a very strong π-donor to Fe3+ and a 
weak π-acceptor from Fe2+. Upon going from Fe3+ to Fe2+, 
the d-orbitals increase in energy due to the decrease in 
Zeff, and this leads to the enhancement of back-bonding, but 
yet low as compared with σ-donation from the porphyrin 
ring. For the low-spin Fe2+ heme complex, the effects of 
strong σ-donation by the porphyrin are evidenced by the 
0.7 eV shift of the Fe L-edge spectrum of the Fe2+ heme 
complex to higher energy relative to the Fe L-edge spectrum 
of the Fe2+ non-heme complex.28
The P450CLA-exhibited affinity to molecules containing 
β-lactamic, oxazole and alkyl amine moieties is consistent 
with a putative participation in the clavulanic acid 
biosynthesis
Considering that S. clavuligerus knockouts of orf10 
failed to produce clavulanic acid, the gene is a candidate for 
a protein which is necessary for the synthesis of clavulanic 
acid. The missing steps in the clavulanic acid synthesis 
pathway when this protein is absent need to be identified. 
The first four steps of the clavulanic acid anabolism have 
been elucidated, as well as the last, in which clavaldehyde 
is converted to clavulanic acid. 
However, the steps responsible for the conversion of 
clavaminic acid to clavaldehyde remain to be elucidated and 
involve oxidative deamination and epimerization reactions 
(equation 1) requiring a P450-like enzyme such as the one 
encoded by the orf10.
 (1)
Therefore, a series of compounds containing β-lactam, 
oxazole and alkyl amine moieties, which compose the 
Figure 2. Spectroscopic characteristics of the ferrous CO-complex of 
P450CLA. (A) Alectronic absorption spectra of the resting form (a) and 
of the ferrous CO-complex of P450CLA (b) and (B) MCD spectrum 
of resting form (a) and of the ferrous CO-complex with a reminiscent 
non CO-complex ferrous form (b). The spectra were obtained as described 
in the Experimental section.
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clavulanic acid structure (Figure S4), were probed for the 
capacity to promote P450CLA spectral changes that are 
indicative of coordination with heme iron.
The spectral changes observed in the presence of the 
probed compounds indicate that, similarly to P450CLA, 
the orf10-encoded protein exhibits high affinity for the 
imidazole ring and this moiety induces the spectral changes 
promoted by the exogenous ligands in which it is present. 
Interestingly, similar spectral features were observed in 
the presence of ampicillin, in which thiazole, and not 
imidazole, was present. In addition, it was observed that 
alkylamino groups not associated to a cyclic structure 
promoted spectral changes in P450CAM different from 
those observed when it was associated to the imidazole 
moiety. Taken together, these results suggest that the 
oxazole moiety may be responsible for the affinity of a 
precursor of clavaldehyde for the P450CAM heme iron. The 
spectral changes were observed before and after addition of 
dithionite, except for glycylhistidine, which did not exhibit 
affinity for ferrous P450CAM.
The spectral changes observed for P450CAM in the 
presence of exogenous ligands before and after dithionite 
addition are summarized in Table S1.
The orf10-encoded protein is converted to a high valence 
state by tert-butylhydroperoxide and promotes homolytic 
scission of the O−O bond
Based on the previous report29 about the capacity of 
P450 to promote cleavage of peroxides, the reactivity 
of P450CLA with tert-BuOOH was also investigated 
(Figures 3 and 4). EPR measurements of the resting protein 
(Figure 3, line a and gray line for the simulated spectrum) 
exhibited an anisotropic EPR signal in the g = 2 region 
(g values = 2.417, 2.245, 1.919), confirming that most of the 
P450CLA iron had spin state S = ½,29 which is consistent 
with P450 cytochrome.
Organic hydroperoxides could support several 
P450-catalyzed reactions by providing oxidation 
equivalents derived from the scission of the peroxide O−O 
bond. The study of the reaction of cumene hydroperoxide 
with rabbit microsomal P450 demonstrated that P450 
promotes homolytic scission of O−O bond with generation 
of alkoxyl radical as the primary free radical species. 
Methyl radical was detected as secondary as well as 
peroxyl radical whose formation was dependent of the 
availability of molecular oxygen to react with methyl 
radical. Here, the reaction of P450CLA with tert-BuOOH 
was investigated by both direct EPR of heme iron at liquid 
helium temperature and by using spin trapping for the 
assignment of primary and secondary free radical species. 
Figure 3 shows that the addition of tert-BuOOH to the 
P450CLA solution led to progressive disappearance of the 
heme iron EPR signal with concomitant appearance of a 
free radical signal (g = 2.0348, 2.0083, 2.0022) assigned 
to a peroxyl radical (Figure 3A, lines b to d and inset). The 
disappearance of the heme Fe3+ signal is consistent with 
the conversion of the resting enzyme to the high valence 
oxoferryl form (FeIV=O) since a heterolytic cleavage of 
tert-BuOOH would result in the formation of a ferryl 
(FeIV)-oxo π-cation radical, which would have a detectable 
distinctive EPR signal. While the heme iron EPR signal 
Figure 3. Continuous wave EPR spectra of P450CLA in the course of 
the reaction with tert-BuOOH. (A) P450CLA was studied using EPR 
before and after the addition of tert-BuOOH. Line a corresponds to the 
spectrum of P450CLA before the addition of tert-BuOOH and the gray 
line the simulated spectrum with g = 2.417, 2.245, 1.919 assigned to the 
ferric low-spin P450CLA heme iron. The set of lines around 330 mT 
obtained after the addition of tert-BuOOH is assigned to a radical formed 
as shown in the inset (the thin line in the inset is the spectral simulation 
with g = 2.0348, 2.0083, 2.0022). The spectrum showed as line f was 
obtained after thaw and mixing. (B) Linear decrease of Fe3+ EPR signal 
intensity (closed circle) with concomitant non-linear EPR radical 
formation (open circle).
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decayed linearly along the time course reaction (90 s), the 
peroxyl radical signal exhibited a hyperbolic growing up to 
30 s reaction and decayed at subsequent times (Figure 3B). 
The shaking of the sample at 60 s reaction time restored the 
maximal intensity of the peroxyl EPR signal (Figure 3A, 
line f). This behavior can be rationalized by the molecular 
oxygen dependence for the peroxyl radical formation. As 
mentioned by Barr et al.,29 who previously investigated 
the reaction of rabbit P450 with cumene hydroperoxide by 
using EPR spin trapping technique, the reaction involves 
the initial homolytic scission of the peroxide O−O bond 
to produce the cumoxyl radical. In the following, the 
β-scission of the cumoxyl radical produced methyl radical 
that, in turn, produced peroxyl radical by reaction with 
molecular oxygen. This proposal was corroborated by the 
absence of peroxyl-DMPO adduct signal in the absence 
of molecular oxygen. The authors concluded that the 
DMPO peroxyl radical adduct detected in the presence 
of oxygen was due to the methylperoxyl radical formed. 
Similarly, in the system presented here, the β-scission of 
the butyloxyl radical produced methyl radical that reacted 
with molecular oxygen to produce methylperoxyl free 
radical. The molecular oxygen depletion was responsible 
for the EPR signal decay after 30 s and the shaking of 
the sample restored the signal intensity by replacing the 
exhausted reagent.
The identity of primary and secondary radicals produced 
by the reaction of P450CLA tert-BuOOH was investigated 
by EPR in the presence of two concentrations of the spin 
trapping DMPO: 160 × 10-3 mol L-1 and 650 × 10-3 mol L-1 
(Figure 4).
The EPR spectra obtained with 650 × 10-3 mol L-1 
DMPO in the presence of tert-BuOOH was a composite 
of three different free radicals (Figure 4, line b) identified 
by simulation as tert-BuO•, •CH3 and a peroxyl radical. A 
simulation of the spectrum of the DMPO-trapped adducts 
provided the following EPR parameters: g = 2.0059, 
aN = 1.500 mT and aβΗ = 1.615 mT for the alcoxyl 
adduct; g = 2.0057, aN = 1.630 mT and aβH = 2.350 mT 
for the methyl adduct and g = 2.0058, aN = 1.400 mT, 
aβH = 1.160 mT and aγH = 0.125 mT for the peroxyl adduct. 
The same EPR signals were present at 160 mmol L-1 DMPO 
(Figure 4, line c); however, while no significant decrease of 
methyl and peroxyl radical signals was observed, the signal 
assigned to butyloxyl radical decreased around fivefold 
consistent with tert-BuO• as the primary radical produced 
by homolytic scission of peroxide O−O bond. 
Conclusions
The present study shows, for the first time, a 
spectroscopic characterization of P450CLA that was 
consistent with a P450 protein and also with the well-known 
assignment of orf10 as a P450 gene.1-4 In addition the 
affinity for exogenous ligands mimicking the structure of 
metabolites of clavulanic acid pathway and reactivity with 
organic peroxide were also characterized. In this regard, 
special attention has been paid to P450s catalysis in view 
of a diversity of potential applications for the enzyme 
such as cost-effective synthesis, the degradation of toxic 
compounds and many other uses. Therefore, rational 
engineering of P450s using techniques such as in vitro 
evolution and site-directed mutagenesis will be required 
to meet these objectives,30 allowing efficient tailor-made 
P450s to become available. Such approaches could be also 
applied to CYP105M1 to obtain new types of secondary 
metabolites or to increase clavulanic acid production. 
Orf10-disrupted mutants of S. clavuligerus have been 
shown to lack clavulanic acid production. Such mutants 
restored their clavulanic acid production by using a plasmid 
carrying a functional copy of orf10.4,31,32 Transformed 
S. clavuligerus cells carrying multiple orf10 and orf11 
copies have shown more than 100% increase in clavulanic 
acid production over non-transformed cells5 and this result 
indicates the potential application of the enzymatic function 
of CYP105M1 that could be improved by engineering a 
more efficient enzyme or replacing the original one.
Figure 4. EPR of radical adducts from the P450CLA/tert-BuOOH 
reaction, spin trapped using DMPO. DMPO spin trap was added to 
P450CLA samples at two distinct concentrations (650 × 10-3 and 
160 × 10-3 mol L-1, lines b and c, respectively). Line a represents the 
spectrum obtained in the presence of DMPO 650 × 10-3 mol L-1 and the 
absence of tert-BuOOH. Radical formation was initiated by the addition of 
375 × 10-3 mol L-1 tert-BuOOH to the samples. Three radical adducts were 
identified: the alcoxyl adduct (tert-BuO•), with g = 2.0059, aN = 1.500 mT, 
aβΗ = 1.615 mT; the methyl adduct (•CH3), g = 2.0057, aN = 1.630 mT, 
aβH = 2.350 mT and the peroxyl adduct, g = 2.0058, aN = 1.400 mT, 
aβH = 1.160 mT, aγH = 0.125 mT and indicated in the simulated spectrum. 
At the highest DMPO concentration used, the alcoxyl (tert-BuO•) signal 
was accentuated and predominated.
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Supplementary Information
Supplementary Information shows P450CAM primary 
structure, SDS PAGE of P450CAM and far UV CD of the 
purified protein. This material is available free of charge 
at http://jbcs.sbq.org.br, as PDF file.
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